Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 31 referrals (62) Apply Article 31 referrals filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 107i procedures (6) Apply Article 107i procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (4) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (7) Apply Centrally authorised product(s) filter Nationally authorised product(s) (1) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (1) Apply Accelerated assessment filter Additional monitoring (5) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

8 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 20 procedures Remove Article 20 procedures filter

Categories Veterinary Remove Veterinary filter Human Remove Human filter

Referral safety status Yes Remove Yes filter

Referral status European Commission final decision Remove European Commission final decision filter

Sort by

List item

Referral: Janus kinase inhibitors (JAKi)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/01/2023, EC decision date: 10/03/2023, Last updated: 22/05/2023
List item

Referral: Rubraca

rucaparib, associated names: Rubraca, Article 20 procedures
Status: European Commission final decision, opinion/position date: 21/07/2022, EC decision date: 21/09/2022, Last updated: 17/10/2022
List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Yondelis

trabectedin, associated names: Yondelis, Article 20 procedures
Status: European Commission final decision, opinion/position date: 24/07/2020, EC decision date: 24/09/2020, Last updated: 09/10/2020
List item

Referral: Carbamazepin Tillomed

carbamazepin, associated names: Carbamazepin Tillomed, Carbamazepina Tillomed, Karbamazepin Tillomed, Karbamazepina Tillomed, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 25/06/2020, Last updated: 21/07/2020
List item

Referral: Xeljanz

tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020
List item

Referral: Lemtrada

alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020
List item

Referral: Lartruvo

olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019

8 results

Referral: Janus kinase inhibitors (JAKi)

Referral: Rubraca

Referral: Picato

Referral: Yondelis

Referral: Carbamazepin Tillomed

Referral: Xeljanz

Referral: Lemtrada

Referral: Lartruvo